Program

Learning objectives

  • Improve your ability to treat glaucoma based on new research findings, drug and device development(s).
  • Introduce newest techniques, how it could affect previous best practices
  • Identify newest research and future directions
  • Updates on MIGS
  • Updates on newest and pipeline drugs and their underlying modes of action
  • Learn about the newest, often unpublished trabecular meshwork, optic nerve, uveal scleral & other outflow research
  • Discuss the implications of this new research on Glaucoma drug and device development
  • Promote increased opportunities for collaborative scientific research and publications, provide a collegial environment and encourage new investigators

An application has been made to the EACCME® for CME accreditation of this event



Wednesday September 25, 2019


Thursday
September 26, 2019
07:30-20:00 Registration open
07:30-09:30 Table top setup for exhibitors
10:00–20:00 Exhibition open
07:30-15:00 Poster mounting
08:30–10.00 Session 1: Neuroprotection
08:30-08:40 1.1. Introduction
John Samples
08:40-09:00 1.2. Concepts of proving neuroprotection
Richard Lee
09:00-09:20 1.3. Concept of trabecular protection from brimonidine to rho kinase inhibitor
Ernst Tamm
09:20-09:40 1.4. Finding the Ying and Yang of Rho with a blue native gel
Paul Knepper
09:40-10:00 Questions & Answers
John Samples, moderator
10:00–10:30 Coffee Break
10:30–12:00 Session 2: Outflow drugs
10:30-10:50 2.1. The vision of Dave Epstein: Why we need an outflow drug
Casey Kopczynski
10:50-11:10 2.2. Rho kinase inhibitors as a class: A multitude of biological effects
Dan Stamer
11:10-11:30 2.3. Rho kinase inhibitors in glaucoma: Basic science studies
Ernst Tamm
11:30-11:50 2.4. Rho kinase inhibitors in Japan
Casey Kopczynski
11:50-12:00 Questions & Answers
Dan Stamer, moderator
12:00-14:00 Lunch Break
14.00–15.30 Session 3: Netarsudil
14:00-14:20 3.1. Clinical studies on Netarsudil
Shan Lin
14:20-14:40 3.2. Approval of Netarsudil and initial experience with its clinical use in the US
Casey Kopczynski
14:40-15:00 3.3. Clinical studies on Netarsudil combined with a prostaglandin
Casey Kopczynski
15:00-15:20 3.4. Side effects of Netarsudil
Shan Lin
15:20-15:30 Questions & Answers
Shan Lin, moderator
15:30–15:45 Coffee Break
15:45–17:15 Session 4: Glaucoma therapy in the future
15:45-16:05 4.1. What will the future of glaucoma therapy be like? How many bottles?
John Samples
16:05-16:25 4.2. The far future of glaucoma therapy
Dan Stamer
16:25-16:45 4.3. Development time lines; availability of the class; what about similar classes such as the serine kinase class
Casey Kopczynski
16:45-17:05 Questions & Answers
John Samples, moderator
17:30-20:00 An Amsterdam-spirited welcome reception at the congress venue
Friday
September 27, 2019
07:00–17:30 Registration open
08.00–17:30 Exhibition open
08:30–10.00 Session 5: Basic science 1
08:30-08:50 5.1. The genetics of glaucoma
John Samples
08:50-09:10 5.2. The biochemistry of trabecular and uveoscleral outflow
Ernst Tamm
09:10-09:30 5.3. The common themes in the biochemistry of glaucoma: Misfolded proteins, cytotoxicity and trabecular protection
John Samples
09:30-09:50 5.4. Glaucoma as a disease of perfusion IOP and intracranial pressure
Ingrida Januleviciene
09:50-10:00 Questions & Answers
Ernst Tamm, moderator
10:00–10:30 Coffee Break
10:30–12:00 Session 6: Basic science 2
10:30-10:50 6.1. Mitochondria and glaucoma
Miriam Kolko
10:50-11:10 6.2. The biology of exfoliation biochemistry glaucoma: Past and future
Ernst Tamm
11:10-11:30 6.3. Global prevalence of glaucoma
Rupert Bourne
11:30-11:50 6.4. Glaucoma in Asia
Shan Lin
11:50-12:00 Questions & Answers
Ernst Tamm, moderator
12:00–14:00 Lunch Break
14:00-15:30 Session 7: Pressure fluctuation and glaucoma
14:00-14:20 7.1. The biology of pressure fluctuation in glaucoma
Dan Stamer
14:20-14:40 7.2. Glaucoma and pressure fluctuation
Kaweh Mansouri
14:40-15:00 7.3. Corticosteroid induced glaucoma
Dan Stamer
15:00-15:20 7.4. Clinical evaluation of the optic nerve
Hans Lemij
15:20-15:30 Questions & Answers
Dan Stamer, moderator
15:30–15:45 Coffee Break
15:45–17:00 Poster walk session
17:30-20:00 Various activity options will be offered to get to know Amsterdam, or go out and draw your own plans.
20:30-23:00 Optional Congress Dinner at downtown location
Saturday
September 28, 2019
08:00–17:30 Registration open
08:00–17:30 Poster tear down
08.00–16:00 Exhibition open
16:00-20:00 Exhibition tear down
08.30–10.00 Session 8: Future technologies
08:30-08:50 8.1. Foibles and flaws in OCT interpretation
Hans Lemij
08:50-09:10 8.2. Measuring the eye: angle and optic nerve
Shan Lin
09:10-09:30 8.3. TBA
Alon Harris
09:30-09:50 8.4. Treating angle closure now and in the future
Shan Lin
09:50-10:00 Questions & Answers
Shan Lin, moderator
10:00-10:30 Coffee Break
10:30–12:00 Session 9: Medical therapies
10:30-10:50 9.1. Current and future role of fixed combination therapy in glaucoma
Tasos Konstas
10:50-11:10 9.2. Alternative molecules in the treatment of glaucoma
John Samples
11:10-11:30 9.3. Interventions to improve adherence in glaucoma
Tasos Konstas
11:30-11:50 9.4. The toxicity of ophthalmic preservatives
Andrew Tatham
11:50-12:00 Questions & Answers
John Samples, moderator
12:00–14:00 Lunch Break
14.00–15.30 Session 10: Surgical options for glaucoma 1
14:00-14:30 10.1. Antimetabolites and glaucoma surgery
Tony Fea
14:30-15:00 10.2. The categories and future of MIGS
Kaweh Mansouri
15:00-15:30 10.3. Subconjunctival to anterior chamber shunts
Andrew Tatham
15:30-15:45 Questions & Answers
John Samples, moderator
15:45–16:00 Coffee Break
16:00–17:15 Session 11: Surgical options for glaucoma 2
16:00-16:20 11.1. Suprchroidal shunts
Tony Fea
16:20-16:40 11.2. Canal based surgery
Kaweh Mansouri
16:40-17:00 11.3. Improvements in cyclodestruction P3,G6 and Micropulse
Shan Lin
17:00-17:20 11.4. The future of neuroprotection
Richard Lee
Questions & Answers
John Samples, moderator

Social Program

See Social Program

Tours

Information about optional tours and local pearls will be posted closer to the congress dates.

Some Important Dates

July 1, 2019 Deadline early registration fee
June 15, 2019 Closing poster abstract submission (extended!)
June 22, 2019 Accepted poster abstracts notification (extended!)
September 9, 2019 Deadline regular registration fee

Kugler Publications

Kugler Publications

Postal address:
P.O. Box 20538
1001 NM Amsterdam
The Netherlands
Tel: +31 20 68 45 700
www.kuglerpublications.com
info@kuglerpublications.com